A phase I imaging and safety study of intravenous 131-I-TM-601 [TM-601-I-131] labeled chlorotoxin in patients with recurrent or refractory somatic and/or cerebral metastatic solid tumors
Phase of Trial: Phase I
Latest Information Update: 18 Jun 2009
At a glance
- Drugs TM 601 I-131 (Primary)
- Indications Astrocytoma; Breast cancer; Colon cancer; Glioma; Non-small cell lung cancer; Pancreatic cancer; Paraganglioma; Prostate cancer; Renal cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors TransMolecular
- 18 Jun 2009 Results discussed in an oral presentation at the Society for Nuclear Medicine Annual Meeting, reported by TransMolecular.
- 01 Oct 2008 Added end date, from clinicaltrials.gov record.
- 01 Oct 2008 Status changed from active, no longer recruiting to completed, from clincialtrials.gov record.